Latest Market Activity News

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

Pursuit Minerals Limited has had its trading suspension lifted following the release of its Pre-Feasibility Study and a capital raising announcement, signaling renewed investor interest.

Oakridge International reports solid growth in healthcare technology revenues and product development progress, while navigating a potential legal claim from Teko International.

Cadoux Limited has made significant progress in its High Purity Alumina (HPA) project and its 50% owned Minhub rare earths processing initiative, advancing engineering design and market engagement amid growing global demand for critical minerals.

Nutritional Growth Solutions reports improved cash flow and cost savings amid leadership changes, setting the stage for renewed growth in FY26.

Findi Limited’s trading suspension is expected to end on 30 January 2026 following satisfactory responses to ASX queries, reopening the stock to market activity.

Paterson Resources has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information exists. The company points to imminent drilling results from its Grace Project as the likely catalyst for market activity.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

ImpediMed reported a solid Q2 FY26 with $3.9 million in revenue and significant reimbursement gains for its lymphoedema technology, while launching new US Heart Health and Wellness initiatives.

Powerhouse Ventures reports its inaugural operating cash flow positive quarter alongside strong fund performance and strategic fund launches, signalling a turning point for the investment house.

Biome Australia Limited has delivered its strongest quarterly financial performance to date, with sales revenue surging 41% year-on-year to $6.5 million and maintaining eight consecutive quarters of positive EBITDA.

Euro Manganese has confirmed no material changes in its operations amid recent spikes in market activity, reassuring investors and regulators alike.